1 / 39

BOTULINUM TOXIN

BOTULINUM TOXIN. BY: MAICA GALVEZ-VERGARA M.D. Botulinum toxin type A. neurotoxin protein Clostridium botulinum Gram-positive rod shaped anaerobic spore-former bacterium Botulism Latin botulus = "sausage shape” food poisoning. Common Indications for Bt-A. Spasmodic Torticollis

mingan
Download Presentation

BOTULINUM TOXIN

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. BOTULINUM TOXIN BY: MAICA GALVEZ-VERGARA M.D.

  2. Botulinum toxin type A • neurotoxinprotein • Clostridium botulinum Gram-positive rod shaped anaerobic spore-former bacterium • BotulismLatinbotulus = "sausage shape” • food poisoning

  3. Common Indications for Bt-A • Spasmodic Torticollis • Blepharospasm • Hemifacial Spasm • Post-Stroke Spasticity • Cerebral Palsy • Dystonia • Various movement disorders • Aesthetics (Wrinkles) • Hyperhidrosis • Square face and other remodelling indications • Spasmodic dysphonia • Myofascial and other Pain • Headache, migraine • Drooling • Etc., etc., etc.

  4. Structure of Botulinum Toxin Disulfide bond Light chain: the molecule’s toxic fraction Heavy chain: responsible for specificity of each serotype Botulinum Toxin is inactivated by heat

  5. Mechanism of Action • Botulinum Toxins block the exocytosis of acetylcholine at the motor endplate, thereby making neuromuscular transmission impossible

  6. The mechanism includes 3 stages

  7. Binding to the Presynaptic Membrane

  8. Internalization of the Toxin

  9. Inhibition of Exocytosis of ACTH • SNARE (SNAP receptor proteins) • SNAP-25 (SyNaptosomal Associated Protein 25 kDa • syntaxin • Synaptobrevin or VAMP • (Vesicular Associated Membrane • Protein)

  10. Recovery by Neuronal Plasticity

  11. ADVANTAGES: • Safe and rapidly administered • Effects are profound • 99% successful • Painless • No recovery time • Technically straightforward to use • Effects are reversible w/in an acceptable limit of time • Complications are rare and self-limiting

  12. DISADVANTAGES: Irreversibility or length of therapeutic effect.

  13. CONTRAINDICATIONS • Hypersensitivity to ingredients ( albumin, sodium chloride botulinum toxin ) • Neuromuscular dx. (myasthenia gravis, motor neuron disease) • Patients treated with other drugs that may interfere with neuromuscular transmission; aminoglycosides, polymixins, penicillamine, quinine, calcium channel blockers neuromuscular blocking agents. • Pregnancy and lactation • Patients in anti-coagulation therapy • Inappropriate anatomy ( skin laxity photo damage ) • Poor psychological adjustment

  14. Bt-A Indications in Aesthetics • Dynamic wrinkles of the glabella • Dynamic wrinkles in the forehead • Dynamic wrinkles around the eyes (« crow’s feet ») • Slight facial asymmetry • Wrinkles in the area around the platysmal muscle and the neck

  15. Other Indications for Bt-A in Aesthetics. • Hyperhidrosis underarms palms

  16. Square face and other remodelling indications • Gummy smiles • Calf contouring • Meso Botox

  17. Different BTXA’s • Botox - Allergan Irvine, CA • BTXA - Lanzhou, China • Refinex - China • Dysport - Wrexam, Wales UK • Korea – Neurotox, Zentox, Botulax • Xeomin (incobotulinumtoxinA) Merz Pharmaceuticals, North Carolina

  18. BTXA – 2-4 units per injection site. Allergan China and Neurotox Dysport – 5-10 units per injection site. 100 units/vial Dilute to 2.5cc of NSS to make 2units of .05ml tuberculin syringe. 500 units/vial Dilute to 2.5cc of NSS to make 5units of .05ml tuberculin syringe. Dose

  19. Pharmacokinetics • Time to action: 24 to 72 hours • Time to peak: 8-15 days after • Duration of action: 3 - 6 months (longer in certain indications • After about the 7th injection, this period is significantly prolonged

  20. TOXICITY • 2500 TO 3000 units in a 70kg human based on the median lethal dose of 40 units / kg. • Single dose of 500 units may produce acute symptoms and signs of botulism.

  21. Facial Muscles • Frontalis> elevates brows. Forehead lines • Corrugators> pull eyebrows medially Procerus, Depressor supercilli> pulls eyebrow down medially. Frown lines • Orbicularis oculi> depresses brows esp. laterally. Crows feet

  22. Dynamic wrinkles of the forehead

  23. Korean Recommendations

  24. Axillary hyperhydrosis • Positive starch-iodine test. 50 units to 100 units/ axilla. • Palmar hyperhydrosis 50 units to 100 units/ hand.

  25. COMPLICATIONS

  26. Areas To Avoid • Around the orbit (lessthan 1 cm) • Lateral area of the browlessthan 1 fingerbreath • Lowereyelid – Neg. Snap test • Lower face (nasolabial) • Around the mouth

  27. Rare Secondary Effects • Pain, burning sensation • Hematoma, edema • Ptosis, drooping of eyelid- naphcon A or apraclonidine 0.5% eye drops. • Always REVERSIBLE and related to dose and • individual sensitivity of each patient

  28. MEPHISTO LOOK…. SPOCK • Usually resolves in weeks • May consider injection at the arch, lateral side to bring down the brow.

  29. FROZEN EXPESSIONS

  30. LOCAL • PAIN • SWELLING • EDEMA • ERYTHEMA • HEMATOMA • RASH • BRUISING • ECCHYMOSIS • TENDERNESS • HEADACHE • SHORT TERM PARESTHESIA

  31. REGIONAL • ASSYMETRY • LOSS OF FACIAL EXPRESSION • INCOMPLETE MUSCLE PARALYSIS

  32. SYSTEMIC • NAUSEA • FATIGUE • SEVERE GENERALIZED WEAKNESS • MALAISE • FLULIKE SYMPTOMS • ALLERGY 2NDARY TO ALBUMIN

  33. POINTS TO PONDER • KNOW YOUR ANATOMY WELL. • KNOW YOUR PRODUCTS WELL. • KNOW YOUR PATIENTS WELL IF POSSIBLE. • USE MINIMUM DOSAGING. • FOLLOW UP IN 2 WEEKS. • ALWAYS TAKE BEFORE AND AFTER PICTURES.

  34. THANK YOU VERY MUCH !!!

More Related